IP Library Assignment 036504/0749
Patent Assignment
Reel/Frame 036504/0749

Change of Name

Recorded: 2015-08-28 Pages: 4
Assignor
ALDEXA THERAPEUTICS, INC.
Executed: 2014-03-17
Assignee
ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Patent: 8,940,721 →
Application: 13/175,218 →
Publication: US 2011/0263645
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Apr 24, 2012
From: NEURON SYSTEMS, INC
To: SQUARE 1 BANK
Reel/Frame 028095/0947 →
Assignment of Assignor's Interest Mar 5, 2013
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 029925/0597 →
Change of Address of Assignee Mar 5, 2013
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 029926/0355 →
Change of Name Mar 5, 2013
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 029926/0357 →
Release of Security Interest Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →